Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isolated epstein-barr virus BZLF2 proteins that bind MHC class II beta chains

Isolated epstein-barr virus BZLF2 proteins that bind MHC class II beta chains

US Patent 5726286 · Granted Mar 10, 1998

Estimated economic value: $45,198,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of producing heterodimeric antibodies2025
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus inf2025
Recombinant virus with diminished latency and methods of using same2025
Antibodies and methods for the diagnosis, prevention, and treatment of Epstein B2024
Epstein-barr virus vaccines2024
ST2 antigen binding proteins2024
Antibodies and methods for the diagnosis and treatment of Epstein Barr Virus inf2024
Recombinant virus with diminished latency and methods of using same2022
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus inf2022
ST2 antigen binding proteins2021
Epstein-Barr virus vaccines2020
BCMA antigen binding proteins2019